SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports ...

On Sunday the Democratic Republic of the Congo (DRC) reached a significant milestone in its fight against the Ebola outbreak, as the last patient was discharged.The recovery marks the start of a ...

NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 ...

Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery programmable therapeutics, and point-of-care diagnostics, today announced an expansion of its Global Disease ...

The last Ebola patient in Congo’s Kasai province was discharged Sunday. No new cases have been detected since Sept. 25. The ...

The countdown to declare the end of an Ebola outbreak in the Democratic Republic of Congo (DRC) has begun after the last ...

Yesterday the World Health Organization (WHO) confirmed that last patient being treated for Ebola virus disease in an ...

The World Health Organization says the last Ebola patient in Congo's recent outbreak has been discharged. No new cases have been reported since September 25. Sunday's announcement started a ...

The last Ebola patient in the Democratic Republic of the Congo (DRC) has been released from a treatment centre in Kasai ...

The California-based firm said that its VeriClear EbV MARV Rapid Antigen Test will be used for the detection and differentiation of Ebola and Marburg virus infections.

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV ...

The Democratic Republic of the Congo marks a pivotal moment in its fight against Ebola as the last patient is discharged from ...